Conference abstract · 25 Jun 2021
Research articlePublished 2019
Ki 67 as Prognostic Factor in Surgically Resected Pancreatic Ductal Adenocarcinoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Pancreatic ductal adenocarcinoma is one of the most aggressive neoplasms, with a poor prognostic and overall survival, most of the patients (over 80%) being diagnosed in advanced stages of the disease, either with distant metastasis or with the locally unresectable tumor. The Ki-67 antigen is a nuclear antigen expressed in all cellular phases (except for the G0 phase) and a high Ki-67 index can be correlated with a recurrence rate of tumor and survival.Aim: The aim of our study was to demonstrate if the Ki-67 index can be used as a negative prognostic factor for survival.Methods: We reviewed retrospectively all patients with pancreatic ductal adenocarcinoma (confirmed histologically) and were selected only those with resectable tumors (19.5%). For these patients, immunoreactivity for Ki-67 was evaluated according to the percentage of positive tumor nuclei. The survival was calculated from the data of surgery to a patient’s death.Results: 19.5% of patients were diagnosed with surgically resectable tumors, with a mean tumor’s size of 3.3 cm. The overall survival rate at 2 years was 21.15%. The patients with a Ki-67 index over 80% had a significantly lower average survival than the other patients.Conclusions: The immunohistochemistry staining for Ki-67 can be applied as a prognostic marker for survival in resectable ductal pancreatic adenocarcinoma.
Subjects
SurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 17 Jul 2016
Solid pseudopapillary tumor of the pancreas: A population-based comparison with pancreatic ductal adenocarcinoma
Research article · 20 Oct 2016
Prognostic Impact of Cancer Stem Cell-Like Phenotypes in Pancreatic Ductal Adenocarcinoma
Article · 12 Dec 2023
The Influence of Aspirin Intake on Survival after Primary Resection of Pancreatic Ductal Adenocarcinoma
Conference abstract · 27 Jul 2021
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
More from this journal
The newest in Journal of Surgery.
Brief report · 1 Dec 2025
Innovations in Sutures for Abdominal Wall Repair
Brief report · 1 Dec 2025
Surgical Checklists: Improving Safety and Efficiency
Commentary · 1 Dec 2025
Thermal Injury In Vascular Surgery: Minimizing Risks
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Surgery
- SubjectSurgery
- BylineArticles whose byline prints “Florina-Delia Andriesi-Rusu”
- BylineArticles whose byline prints “Ana-Maria Trofin”
- BylineArticles whose byline prints “Irene Cianga-Spiridon”
- BylineArticles whose byline prints “Nutu Vlad”
- BylineArticles whose byline prints “Alin Vasilescu”
- BylineArticles whose byline prints “Eugen Târcoveanu”
- BylineArticles whose byline prints “Cristian Lupașcu”

